VICRA 25 contains Empagliflozin which belongs to the group of medicines called Anti-diabetic drugs. It is used to treat type 2 diabetes in adults, that cannot be controlled by diet and exercise alone. It can also help to prevent heart disease in patients with type 2 diabetes mellitus. It is also used to treat heart failure in adult patients with weak pumping function.
Diabetes can be defined as inability of your body to produce and use enough insulin (a hormone made by pancreas), resulting in abnormal blood glucose levels. It can show symptoms like increased thirst, urination and hunger, blurry vision, numbness in hands or feet, or tiredness. Heart failure occurs when the heart is weak and unable to pump enough blood to the lungs and the rest of the body, creating symptoms like breathlessness, tiredness, and ankle swelling.
Empagliflozin works by blocking a protein (SGLT2) in your kidneys. This results in removal of blood sugar (glucose) in your urine, thus lowering the amount of sugar in your blood. Appropriate diet and exercise can help your body use its blood sugar better. Follow any advice given by your doctor regarding foot care. Prior to the treatment, your doctor may want you to take several blood tests to understand your existing condition.
Before taking VICRA 25, inform your doctor if you have any serious liver, kidney or heart problems, or diabetes type 1. VICRA 25 is not recommended in pregnant or breastfeeding women, therefore consult your doctor before taking. VICRA 25 is not recommended for use in children and adolescents (below 18 years of age).
Due to limited therapeutic experience, elderly patients (above 75 years of age) should consult the doctor before taking VICRA 25. The most common side effects of taking VICRA 25 are low blood sugar, genital infection, frequent urination, rash, itching, thirst, or constipation. Consult your doctor if any of the symptoms get worsen.
It is used to:
VICRA 25 works by blocking a protein (SGLT2) in your kidneys. This results in removal of blood sugar (glucose) in your urine, thus lowering the amount of sugar in your blood. It also helps protect your heart from getting weaker and relieve your symptoms.
Take VICRA 25 as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition. Do not stop taking VICRA 25 unless your doctor advice you to stop.
Stop taking VICRA 25 and consult your doctor immediately if you experience any of the following side effects:
Nausea:
Take this medicine with, or just after meals. Stick to simple meals. Avoid eating oily or spicy foods. Consult your doctor if the symptom does not improve.
Constipation:
Eat plenty of fiber rich foods such as fresh fruits, vegetables, and cereals and drink plenty of water. Exercise more regularly. Consult your doctor if the symptom does not improve.
Stomach pain:
Try to rest and relax. Eat and drink slowly or try to have smaller and more frequent meals. Keep a heat pad on your stomach. If the symptom does not improve, contact your doctor.
Low blood sugar:
Have a fruit juice, glucose tablets or gel, soft drinks, honey, or sugary candy. Check your blood sugar after 10 minutes. If not gained optimum level, take another sugary snack or drink, and check the blood sugar again. If the symptom does not improve, contact your doctor.
VICRA 25 is generally not recommended for use in pregnant women. Consult your doctor before taking it.
VICRA 25 is generally not recommended for use in breastfeeding women. It is not known if this medicine passes into human breast milk, so consult your doctor before taking it.
Do not drive or operate any machines if you feel dizzy after taking VICRA 25.
VICRA 25 should be taken with caution in patients with severe kidney disease and serious infection of the kidney. Consult your doctor before taking it.
VICRA 25 should be used with caution in patients with severe liver disease. Consult your doctor before taking it.
Do not take VICRA 25 if you are allergic to Empagliflozin.
Before taking VICRA 25, inform your doctor if you:
Use in pediatrics:
VICRA 25 is generally not recommended for use in children and adolescents (under 18 years of age). Consult your doctor before taking.
Use in geriatrics:
Due to limited therapeutic experience, elderly patients (above 75 years of age) should consult the doctor before taking VICRA 25.
A. Drug - Drug interactions:
Before taking VICRA 25, inform your doctor if you are taking any of the following medicine:
Overdosage:
If you or anyone else accidentally take too much of VICRA 25, consult your doctor immediately or visit the nearby hospital.
Drug | : | Empagliflozin |
Pharmacological Category | : | Sodium Glucose Cotransporter-2 Inhibitor |
Therapeutic Indication | : | Type 2 diabetes mellitus,Heart failure |
Dosage Forms | : | Tablet |
Can VICRA 25 be used on infants?
No. VICRA 25 is used for adults and not recommended for children and adolescents below 18 years of age. Your doctor will decide the correct dose or select a suitable alternative therapy for your child.
Is VICRA 25 safe in pregnancy?
VICRA 25 is not recommended for use during pregnancy. If you are pregnant, think you may be pregnant or are planning to get pregnant, ask your doctor before taking this medicine. It is unknown if it is harmful for the unborn child.
How VICRA 25 should be taken? Can it be crushed?
No. Do not crush VICRA 25. Take the medicine as advised by your physician. Swallow the medicine with a glass of water. Do not crush or chew the medicine. Your doctor will decide the correct dose and duration for you depending upon your age, body weight and disease condition.
Can VICRA 25 be stopped taking on own?
Do not stop taking VICRA 25 unless your doctor advice you to stop. If you have type 2 diabetes mellitus, your blood sugar levels may increase when you stop taking this medicine.
What precautions do I need to follow while taking VICRA 25?
Patients taking VICRA 25 must inform their doctor about their pre-existing disease conditions like kidney, liver, or heart problems. Patients should also inform if they are pregnant, breast-feeding, having any allergies, serious urinary tract and genital infections, or risk of dehydration. Consult your doctor immediately if you experience any unusual symptoms.
Can VICRA 25 cause hypoglycemia?
Yes. VICRA 25 may cause hypoglycemia (low blood sugar levels). In such case, have a fruit juice, glucose tablets or gel, soft drinks, honey, or sugary candy. Check your blood sugar after 10 minutes. If not gained optimum level, take another sugary snack, or drink, and check the blood sugar again.
What VICRA 25 is used for?
VICRA 25 is used to treat type 2 diabetes in adults, that cannot be controlled by diet and exercise which is also used to prevent and treat heart disease in patients with type 2 diabetes mellitus.
What is the difference between metformin and VICRA 25?
VICRA 25 is an antidiabetic medicine which treats type 2 diabetes by working on the kidneys to prevent the absorption of glucose (blood sugar) resulting in decreased blood sugar level. Metformin is an antidiabetic medicine which acts on stomach and liver to reduce the absorption of sugar that results in regulating the blood sugar level.
What are the side effects of VICRA 25?
The most common side effects of taking VICRA 25 are genital yeast infection (thrush), passing more urine than usual or needing to pass urine more often, itching, rash or red skin, thirst, and or constipation. Consult your doctor if any of your symptoms get worsen over the time.
What is the best time of day to take VICRA 25?
VICRA 25 comes in a tablet form which is generally taken by mouth once a day in the morning with or without food or as advised by your consulting doctor.
What are the dangers of taking VICRA 25?
Patients taking VICRA 25 may experience signs of urinary tract infection such as burning sensation while passing urine, and pain in the pelvis which should be considered serious and doctor should be contacted at the earliest to manage the effect.
1. Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael Posey. Diabetes Mellitus. Pharmacotherapy- A Pathophysiologic Approach. Eighth edition. Page -1263,1264.
2. Uche Anadu Ndefo, Nicole O. Anidiobi, Efrah Basheer, and Angie T. Eaton. Empagliflozin (Jardiance): A Novel SGLT2 Inhibitor for the Treatment of Type-2 Diabetes. NIH National Library of Medicine, National center for biotechnology information. PMC. Pubmed Central. [Revised in January 2015] [Accessed on 18th April 2022] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4450666/
3. NHS Greater Glasgow and Clyde. Studies of Empagliflozin and Its Cardiovascular, Renal and Metabolic Effects (SUGAR-DM-HF). NIH U.S. National Library of Medicine ClinicalTrials.gov. [Revised in September 2020] [Accessed on 18th April 2022] https://clinicaltrials.gov/ct2/show/NCT03485092
4. Boehringer Ingelheim Pharma GmbH & Co. KG. Electronic Medicines Compendium (EMC). [Revised in January 2022] [Accessed on 18th April 2022] https://www.medicines.org.uk/emc/files/pil.5441.pdf
Additional Discount on this product
Please get a call back from our expert
The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.